Pfizer
Laurence Flint, MD, FAAP, currently serves as the Director of Vaccine Clinical Research and Development at Pfizer, where responsibilities include overseeing global clinical vaccine trials and ensuring patient safety. With extensive experience as a Pediatric Hospitalist and Vice Chair of the Department of Pediatrics at Newton Medical Center, Laurence has also contributed as a medical writer and consultant from 2014 to 2021, focusing on pediatric product research and regulatory affairs. Prior roles include leadership positions in clinical research at Novartis Consumer Health and Merck, regulatory science at Johnson & Johnson, and an adjunct professorship at Rutgers University. Laurence holds an MD from Rutgers New Jersey Medical School and is pursuing a Master of Public Health. Additionally, Laurence possesses multiple advanced degrees, including an MBA and an MS in Biology.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.